...
首页> 外文期刊>Marine Drugs >Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells
【24h】

Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells

机译:Sinulariolide通过PI3K / AKT / mTOR信号通路抑制人膀胱癌细胞中的基质金属蛋白酶-2 / -9和尿激酶抑制细胞迁移和侵袭。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Sinulariolide is a natural product extracted from the cultured-type soft coral Sinularia flexibilis , and possesses bioactivity against the movement of several types of cancer cells. However, the molecular pathway behind its effects on human bladder cancer remain poorly understood. Using a human bladder cancer cell line as an in vitro model, this study investigated the underlying mechanism of sinulariolide against cell migration/invasion in TSGH-8301 cells. We found that sinulariolide inhibited TSGH-8301 cell migration/invasion, and the effect was concentration-dependent. Furthermore, the protein expressions of matrix metalloproteinases (MMPs) MMP-2 and MMP-9, as well as urokinase, were significantly decreased after 24-h sinulariolide treatment. Meanwhile, the increased expression of tissue inhibitors of metalloproteinases (TIMPs) TIMP-1 and TIMP-2 were in parallel with an increased concentration of sinulariolide. Finally, the expressions of several key phosphorylated proteins in the mTOR signaling pathway were also downregulated by sinulariolide treatment. Our results demonstrated that sinulariolide has significant effects against TSGH-8301 cell migration/invasion, and its effects were associated with decreased levels of MMP-2/-9 and urokinase expression, as well as increased TIMP-1/TIMP-2 expression. The inhibitory effects were mediated by reducing phosphorylation proteins of the PI3K, AKT, and mTOR signaling pathway. The findings suggested that sinulariolide is a good candidate for advanced investigation with the aim of developing a new drug for the treatment of human bladder cancer.
机译:鼠尾草内酯是从培养型软珊瑚鼠尾草中提取的天然产物,对多种类型的癌细胞的运动具有生物活性。然而,其对人类膀胱癌的作用背后的分子途径仍知之甚少。本研究使用人膀胱癌细胞系作为体外模型,研究了芥酸内酯对TSGH-8301细胞中细胞迁移/侵袭的潜在机制。我们发现西律碘化物抑制TSGH-8301细胞迁移/侵袭,并且其作用是浓度依赖性的。此外,在24小时的窦内酯处理后,基质金属蛋白酶(MMPs)MMP-2和MMP-9以及尿激酶的蛋白表达显着降低。同时,金属蛋白酶(TIMPs)TIMP-1和TIMP-2的组织抑制剂的表达增加与西拉碘化物的浓度增加平行。最后,沙丁胺醇处理也下调了mTOR信号通路中几种关键磷酸化蛋白的表达。我们的研究结果表明,西拉碘化物对TSGH-8301细胞迁移/侵袭具有显着影响,其作用与MMP-2 / -9和尿激酶表达水平降低以及TIMP-1 / TIMP-2表达增加有关。抑制作用是通过减少PI3K,AKT和mTOR信号通路的磷酸化蛋白来介导的。研究结果表明,西拉碘化物是进行高级研究的良好候选者,目的是开发一种新的治疗人膀胱癌的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号